Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).

Sarah B FisherSafia RafeeqKen HessTravis E GrotzPaul MansfieldRichard RoyalBrian BadgwellJason FlemingKeith FournierGary N Mann

Published in: Journal of surgical oncology (2017)

Postoperative BNP measurement after CRS + HIPEC may guide postoperative fluid resuscitation and facilitate identification of patients at risk for major and/or cardiopulmonary complications.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
patients undergoing
prognostic factors
minimally invasive
cardiac arrest
squamous cell carcinoma
patient reported outcomes
risk factors
radiation therapy
rectal cancer
cerebral ischemia